Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema (Q30784200)

26 June 2017

Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema (English)

1 reference

26 June 2017

0 references

0 references

Hideharu Funatsu

1

1 reference

26 June 2017

Hidetoshi Yamashita

2

1 reference

26 June 2017

Hidetaka Noma

3

1 reference

26 June 2017

Tatsuya Mimura

4

1 reference

26 June 2017

Tetsuji Yamashita

5

1 reference

26 June 2017

Sadao Hori

6

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

American Journal of Ophthalmology

26 June 2017

1 reference

26 June 2017

133

1 reference

26 June 2017

1

1 reference

26 June 2017

70-77

1 reference

The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

The 14-year incidence of visual loss in a diabetic population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Diabetic maculopathy. A critical review highlighting diffuse macular edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Diabetic macular edema. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

The role of the vitreous in diabetic macular edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Vascular endothelial growth factor is a secreted angiogenic mitogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

New surgical approach for removing massive foveal hard exudates in diabetic macular edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Cytokines in proliferative vitreoretinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Interleukin 6 induces the expression of vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Photocoagulation for Diabetic Macular Edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Early breakdown of the blood-retinal barrier in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

A follow-up study by vitreous fluorophotometry of early retinal involvement in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Localization of vascular endothelial growth factor in human retina and choroid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

The effect of TNF-alpha and IL-6 on the permeability of the rat blood-retinal barrier in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Interaction between human monocytes and vascular smooth muscle cells induces vascular endothelial growth factor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Disruption of iridial blood-aqueous barrier in experimental diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Quantitative assessment of aqueous flare intensity in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Studies of the blood-aqueous barrier in diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Interleukin-6 (IL-6) gene expression and secretion by cytokine-stimulated human retinal pigment epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Production of interleukin-6 by human retinal pigment epithelium in vitro and its regulation by other cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Vitrectomy for diffuse macular edema in cases of diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Optical cross-sectional observation of resolved diabetic macular edema associated with vitreomacular separation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901269-7

10.1016/S0002-9394(01)01269-7

7 January 2021

Identifiers

DOI

1 reference

26 June 2017

1 reference